FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113662856> ?p ?o ?g. }

• W2113662856 endingPage "13" @default.
• W2113662856 startingPage "1306" @default.
• W2113662856 abstract "Essential thrombocythemia (ET) can be complicated by life-threatening thrombosis and has a risk of converting into acute leukemia. Cytoreductive therapy may reduce the risk of thromboembolic complications. Herein, we report the results of a long-term study of patients with ET treated with anagrelide to control thrombocytosis.Thirty-nine (34 evaluable) patients (median age, 33 years; 24 previously untreated) were enrolled between 1989-1996; the mean platelet count prior to therapy was 1197x10(9)/L. Only 9 out of 34 evaluable patients were at high risk of thrombosis (platelet count more than 1500x10(9)/L). The initial dose of anagrelide (0.5 mg/bid for 7 days) was increased by 0.5 mg/day (maximum dose: 3 mg/day) until a response was seen.A complete response (platelets < 450x10(9)/L for >1 month) was seen in 15 /34 (44%) patients and a partial response (platelets 450-600x10(9)/L for >1 month) was seen in 17/34 ( 50%), so that the some kind of response was seen in 32/34 (94%) of the patients at a median time of 4.2 months after starting treatment. Seventeen patients (50%) are still being treated and have achieved platelet control for a maximum follow-up of 12.5 years. Late onset anemia occurred in 4/39 patients. Three out of 39 patients (8%) had cardiac disorders.Anagrelide appears suitable for controlling thrombocytosis in ET patients over the long-term. This drug may be used in patients younger than 60 years, with the exclusion of women of child-bearing potential and subjects aged 40-60 years with a history of major thrombotic events. Anagrelide should not be administered to patients with cardiac disorders, and a careful approach to patients should include monitoring of heart function before and during treatment." @default.
• W2113662856 created "2016-06-24" @default.
• W2113662856 creator A5006023644 @default.
• W2113662856 creator A5009095647 @default.
• W2113662856 creator A5018295122 @default.
• W2113662856 creator A5056630421 @default.
• W2113662856 creator A5066768069 @default.
• W2113662856 creator A5070563529 @default.
• W2113662856 creator A5076433784 @default.
• W2113662856 creator A5082333992 @default.
• W2113662856 date "2004-11-01" @default.
• W2113662856 modified "2023-10-14" @default.
• W2113662856 title "A long-term study of young patients with essential thrombocythemia treated with anagrelide." @default.
• W2113662856 cites W1964425779 @default.
• W2113662856 cites W1964478853 @default.
• W2113662856 cites W1995607351 @default.
• W2113662856 cites W1996074331 @default.
• W2113662856 cites W1999288841 @default.
• W2113662856 cites W2003597939 @default.
• W2113662856 cites W2016865426 @default.
• W2113662856 cites W2030435811 @default.
• W2113662856 cites W2031752990 @default.
• W2113662856 cites W2034040218 @default.
• W2113662856 cites W2039687934 @default.
• W2113662856 cites W2048752724 @default.
• W2113662856 cites W2062237570 @default.
• W2113662856 cites W2066249318 @default.
• W2113662856 cites W2067426157 @default.
• W2113662856 cites W2076231724 @default.
• W2113662856 cites W2077812003 @default.
• W2113662856 cites W2082786792 @default.
• W2113662856 cites W2082997796 @default.
• W2113662856 cites W2084549813 @default.
• W2113662856 cites W2085170704 @default.
• W2113662856 cites W2092298450 @default.
• W2113662856 cites W2092484653 @default.
• W2113662856 cites W2092924489 @default.
• W2113662856 cites W2095188600 @default.
• W2113662856 cites W2117054170 @default.
• W2113662856 cites W2168062293 @default.
• W2113662856 cites W2317624320 @default.
• W2113662856 cites W2320032845 @default.
• W2113662856 cites W2329964205 @default.
• W2113662856 cites W2341264142 @default.
• W2113662856 cites W2408172393 @default.
• W2113662856 cites W2411499754 @default.
• W2113662856 cites W2419298114 @default.
• W2113662856 cites W2422732236 @default.
• W2113662856 cites W26497377 @default.
• W2113662856 cites W46453237 @default.
• W2113662856 cites W1978965068 @default.
• W2113662856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15531452" @default.
• W2113662856 hasPublicationYear "2004" @default.
• W2113662856 type Work @default.
• W2113662856 sameAs 2113662856 @default.
• W2113662856 citedByCount "21" @default.
• W2113662856 countsByYear W21136628562013 @default.
• W2113662856 countsByYear W21136628562015 @default.
• W2113662856 countsByYear W21136628562016 @default.
• W2113662856 countsByYear W21136628562018 @default.
• W2113662856 countsByYear W21136628562020 @default.
• W2113662856 countsByYear W21136628562022 @default.
• W2113662856 countsByYear W21136628562023 @default.
• W2113662856 crossrefType "journal-article" @default.
• W2113662856 hasAuthorship W2113662856A5006023644 @default.
• W2113662856 hasAuthorship W2113662856A5009095647 @default.
• W2113662856 hasAuthorship W2113662856A5018295122 @default.
• W2113662856 hasAuthorship W2113662856A5056630421 @default.
• W2113662856 hasAuthorship W2113662856A5066768069 @default.
• W2113662856 hasAuthorship W2113662856A5070563529 @default.
• W2113662856 hasAuthorship W2113662856A5076433784 @default.
• W2113662856 hasAuthorship W2113662856A5082333992 @default.
• W2113662856 hasConcept C126322002 @default.
• W2113662856 hasConcept C141071460 @default.
• W2113662856 hasConcept C2776738589 @default.
• W2113662856 hasConcept C2776863199 @default.
• W2113662856 hasConcept C2778461978 @default.
• W2113662856 hasConcept C2779788118 @default.
• W2113662856 hasConcept C2779867487 @default.
• W2113662856 hasConcept C2780829020 @default.
• W2113662856 hasConcept C2780868729 @default.
• W2113662856 hasConcept C2781057849 @default.
• W2113662856 hasConcept C71924100 @default.
• W2113662856 hasConcept C89560881 @default.
• W2113662856 hasConcept C90924648 @default.
• W2113662856 hasConceptScore W2113662856C126322002 @default.
• W2113662856 hasConceptScore W2113662856C141071460 @default.
• W2113662856 hasConceptScore W2113662856C2776738589 @default.
• W2113662856 hasConceptScore W2113662856C2776863199 @default.
• W2113662856 hasConceptScore W2113662856C2778461978 @default.
• W2113662856 hasConceptScore W2113662856C2779788118 @default.
• W2113662856 hasConceptScore W2113662856C2779867487 @default.
• W2113662856 hasConceptScore W2113662856C2780829020 @default.
• W2113662856 hasConceptScore W2113662856C2780868729 @default.
• W2113662856 hasConceptScore W2113662856C2781057849 @default.
• W2113662856 hasConceptScore W2113662856C71924100 @default.
• W2113662856 hasConceptScore W2113662856C89560881 @default.
• W2113662856 hasConceptScore W2113662856C90924648 @default.

• next